Blue Grass Chemical Specialties LLC celebrated 50 years in business in 2019. We are a modern chemical manufacturer, located in New Albany, Indiana, just across the Ohio River from Louisville, Kentucky. Our facility is diverse and flexible, allowing prompt and cost effective production whether it is a simple blending operation, or a complex multi stage precipitation. WHAT WE DO: Blue Grass specializes in aqueous inorganic metal salt solutions and makes some precipitated products along with performing extensive toll manufacturing for other companies. Metal salts are a field in which Blue Grass is a recognized leader. Catalyst, Oil and Gas, Agriculture, Metal Finishing, Photographic, and Electronics are but a few of the industries which rely on our Metal Salt Products. Our modern, well equipped laboratory is professionally staffed allowing us to tailor our metal salt solutions to our customer’s exact specifications. WHY WE DO IT: Customer service is what our business is all about. We work with our customers through every step of a products development to assure that our customer’s exact requirements are met. Blue Grass Chemical Specialties can develop and produce your complex chemical needs safely, efficiently, on time, and on budget. Our modern facilities and professional expertise assure quality control from start to finish. So when you need specialized chemical solutions, give us a call. We’ll show you our formula for success.

Advancing regenerative medicine through the development of a natural biomaterial that restores mother nature’s template to treat disease and injury. ECM scaffolds, in solid form, have been successfully used in more than 10 million human patients to repair a variety of body systems such as musculoskeletal tissues, cardiovascular structures, and non-healing skin wounds, among others. These products have all received FDA clearance. ECM Therapeutics'​ patented ECM hydrogel technology allows for expanded, less invasive applications in multiple disease areas. The first clinical product, EsophaGel, treats Barrett’s esophagus, a precancerous condition that currently has no effective therapy.